EVNIN LUKE sold 21.9% of their position (105.56K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $43.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/8/2026ACC: 0001134657-26-000017
Director10% Owner
Since Apr 2021
-105.56K
Net shares
Net seller
$43.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
105.56K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−20.07K
Price / share
$0.44
Trade value
$8.83K
% of position
4.2%
6/4/2026
482.78K→462.70K
Common Stock
Indirect
Shares
−24.95K
Price / share
$0.40
Trade value
$9.98K
% of position
5.4%
6/5/2026
462.70K→437.76K
Common Stock
Indirect
Shares
−60.55K
Price / share
$0.40
Trade value
$24.22K
% of position
13.8%
6/8/2026
437.76K→377.21K
Total
Net shares
−105.56K
Net value
-$43.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/4/2026 | S · Sale | −20.07K | $0.44 | $8.83K | 4.2% | 482.78K | 462.70K |
| Common Stock Indirect | 6/5/2026 | S · Sale | −24.95K | $0.40 | $9.98K | 5.4% | 462.70K | 437.76K |
| Common Stock Indirect | 6/8/2026 | S · Sale | −60.55K | $0.40 | $24.22K | 13.8% | 437.76K | 377.21K |
| Total | −105.56K | -$43.03K | ||||||
Derivative Transactions0
No derivative transactions reported